Delivery Order SPE2DB22D3501-SPE2DB23FWW57
Award Date 8/16/23
Potential Completion Date 8/17/23
Potential Value $1.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,601.74 firm fixed-price delivery order to Amerisourcebergen Drug Corp for SPRAVATO 84 mg dose pack units of use on January 8, 2026, with completion targeted for January 9, 2026. This non-competitive delivery order, issued under a larger indefinite delivery contract vehicle, represents a pharmaceutical supply fulfillment to support federal military and healthcare system requirements. Amerisourcebergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $7,132 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 84 mg doses of SPRAVATO (esketamine) nasal spray. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 21-22, 2023. No subcontractors or set aside designations were identified. This order supports DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $7,852.37 to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack unit dose systems (UDS), with completion scheduled for November 14, 2025. This firm fixed price delivery order, awarded on November 13, 2025, represents a non-set-aside competitive award and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. SPRAVATO is a nasal spray formulation of esketamine indicated for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,829.09 to AmerisourceBergen Drug Corp for the supply of SPRAVATO 84 mg dose pack UDS (unit dose packages). This firm fixed price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a prescription nasal spray used in treating...
- The Defense Logistics Agency awarded a $5,616.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack UDS (unit dose packs) with a completion date of September 26, 2025. This non-set-aside competitive award was issued on September 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a specialized nasal spray medication indicated for treatment-resistant depression, representing a critical...
- The Defense Logistics Agency awarded a $16,784.75 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 28, 2026, for the supply of Spravato 84 mg dose pack UDS (unit dose system). This non-set-aside competitive award will be completed by January 29, 2026, and is being performed at the contractor's headquarters location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $10,162.71 firm fixed price delivery order contract to provide 4561535214 doses of 84 mg SPRAVATO dose packs. SPRAVATO is an esketamine nasal spray used to treat treatment-resistant depression and post-traumatic stress disorder. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day contract period is July 18 through July 19, 2023, indicating an urgent need to replenish DLA's...
- The Defense Logistics Agency awarded a $7,489.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 84 mg doses of SPRAVATO, to be delivered to a location in Conshohocken, Pennsylvania by October 25, 2023. SPRAVATO is a brand name drug used to treat treatment-resistant depression, and this contract provides doses of that drug to support the Defense Logistics Agency's medical supply program. No set-aside provision was specified for this award. Amerisourcebergen Drug...
- The Defense Logistics Agency issued a $35,746.56 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for SPRAVATO 84 mg dose pack UDS pharmaceutical supply. This delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an...
- The Defense Logistics Agency awarded a delivery order valued at $4,212.06 to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack unit dose systems (UDS) on October 30, 2025, with completion targeted for October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWW57Delivery Order
The Defense Logistics Agency awarded a $1,417.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561835820 SPRAVATO 56 MG DOSE PACK UDS. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will deliver the pharmaceutical products to the same location by August 17, 2023. This delivery order was issued against an existing DLA contract vehicle to supply SPRAVATO, an esketamine nasal spray used to treat treatment-resistant depression and suicidal thoughts in adults. No set aside designation or subcontracting requirements were specified. The award supports DLA's mission to provide medical supplies to military treatment facilities and veterans health programs.
Generated 12/15/23, 6:31 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/16/23 |